Effect of the Use of Dapagliflozin in Patients With Refractory Heart Failure

Abroad (travel likely)RecruitingPHASE4

Conditions

Heart Failure

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Hospital Clínico Universitario de Valencia, Valencia, Spain

    Contact: Study coordinator (Marco Montomoli) · marcomontomoli@hotmail.it
Study leads
  • Marco Montomoli

    Principal Investigator

    Hospital Clínico Universitario de Valencia